Research Use
Also known as Delta Sleep-Inducing Peptide

Function

Primary
Sleep quality · Insomnia
Secondary
Stress response normalization
Mechanism
Hypothalamic peptide — reduces ACTH and somatostatin secretion; modulates delta-wave EEG sleep; antioxidant; normalizes circadian disruption.
Evidence
Pre-clinical / Observational
Research
Small human studies (1970s–80s)

Dosing

Range
100–400 mcg/day
Frequency
Before sleep
Route
Subcutaneous · Intranasal

Cycling

2–3 weeks on / 1 week off.

Benefits

  • ·Deeper delta-wave sleep
  • ·Stress normalization
  • ·Antioxidant in models

Risks

  • ·Variable absorption
  • ·Anecdotal tolerance with frequent use
  • ·Limited modern safety data

Contraindications

  • ·Pregnancy
  • ·Hypersensitivity

Regulatory

Not FDA-approved; research use

Cited Works

  1. Schoenenberger GA. DSIP: a still unresolved riddle. J Neural Transm. 1984;21:367.
Sign in to save favorites & stacks